Dominique Davidson

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Author Correction: SLAMF6 as a drug-targetable suppressor of T cell immunity against cancer.

Author Correction: SLAMF6 as a drug-targetable suppressor of T cell immunity against cancer.

Journal: Nature

Published: March 14, 2026

Targeting phagocytosis checkpoints for cancer immunotherapy.

Targeting phagocytosis checkpoints for cancer immunotherapy.

Journal: Nature reviews. Cancer

Published: October 23, 2025

Anticancer immune responses are hindered by cis interaction of inhibitory checkpoint SIRPα.

Anticancer immune responses are hindered by cis interaction of inhibitory checkpoint SIRPα.

Journal: Science immunology

Published: October 10, 2025

SLAMF6 as a drug-targetable suppressor of T cell immunity against cancer.

SLAMF6 as a drug-targetable suppressor of T cell immunity against cancer.

Journal: Nature

Published: November 20, 2024

CD200R1-CD200 checkpoint inhibits phagocytosis differently from SIRPα-CD47 to suppress tumor growth.

CD200R1-CD200 checkpoint inhibits phagocytosis differently from SIRPα-CD47 to suppress tumor growth.

Journal: Nature communications

Published: October 17, 2024

Suppression of adaptive NK cell expansion by macrophage-mediated phagocytosis inhibited by 2B4-CD48.

Suppression of adaptive NK cell expansion by macrophage-mediated phagocytosis inhibited by 2B4-CD48.

Journal: Cell reports

Published: June 30, 2023

CD47 masks pro-phagocytic ligands in cis on tumor cells to suppress antitumor immunity.

CD47 masks pro-phagocytic ligands in cis on tumor cells to suppress antitumor immunity.

Journal: Nature immunology

Published: February 15, 2023

Cis interactions between CD2 and its ligands on T cells are required for T cell activation.

Cis interactions between CD2 and its ligands on T cells are required for T cell activation.

Journal: Science immunology

Published: August 05, 2022

Inflammatory macrophages exploit unconventional pro-phagocytic integrins for phagocytosis and anti-tumor immunity.

Inflammatory macrophages exploit unconventional pro-phagocytic integrins for phagocytosis and anti-tumor immunity.

Journal: Cell reports

Published: May 07, 2021

Critical Role of Lipid Scramblase TMEM16F in Phosphatidylserine Exposure and Repair of Plasma Membrane after Pore Formation.

Critical Role of Lipid Scramblase TMEM16F in Phosphatidylserine Exposure and Repair of Plasma Membrane after Pore Formation.

Journal: Cell reports

Published: July 22, 2019

Developing combination immunotherapies against cancer that make sense.

Developing combination immunotherapies against cancer that make sense.

Journal: Science immunology

Published: September 19, 2018

AXL confers cell migration and invasion by hijacking a PEAK1-regulated focal adhesion protein network.

AXL confers cell migration and invasion by hijacking a PEAK1-regulated focal adhesion protein network.

Journal: Nature communications

Published: August 16, 2018

Showing 1-12 of 25

Last Updated: 09/26/2026